Accumulating data suggests that both categories of diabetes share intra-islet expression of inflammatory mediators, particularly the cytokine interleukin (IL)-1β, activating a final common pathway of β-cell apoptosis through the nuclear factor (NF)-κB and Fas pathways, resulting in progressive β-cell loss in diabetes [4]. Here, NFKB1 is linked to diabetes mellitus.